SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of February 2006
Commission File Number 000-20181
Sapiens International Corporation N.V.
(translation of registrants name into English)
c/o Landhuis Joonchi
Kaya Richard J. Beaujon z/n
P.O. Box 837
Willemstad
Curaçao, Netherlands Antilles
(599) (9) 7366277
(address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F
Form 20-F X Form 40-F ___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of 1934
Yes ___ No X
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.
#
SAPIENS ANNOUNCES Q4 2005 AND YEAR-END RESULTS
Research Triangle Park, N.C. - February 23, 2006 - Sapiens International Corporation N.V. (NASDAQ and TASE: SPNS) today announced its un-audited results of operations for the year ended December 31, 2005 and its un-audited results of operations for the fourth quarter of 2005.
For the fourth quarter, the Company recorded revenues of $9.8 million compared with $9.9 million in the previous quarter. Revenues for the year totaled $39.4 million compared with $47.8 million in 2004.
Operating loss for the quarter is $0.96 million, compared with $0.94 million in the previous quarter. Operating loss for the year is $5.5 million, compared with $1.7 million for 2004.
Reporting fourth quarter and year-end results, the Company recorded a write off of $250,000 of an institutional receivables management determined it to be uncollectible.
Without the $250,000 write off, operating loss for the quarter would have been $0.71 million, a reduction from the operating loss of $0.94 million reported in the previous quarter.
Net loss for the fourth quarter was $3.1 million, compared with a net loss of $1.6 million in the third quarter of 2005. Net loss for the year was $9.1 million, compared with a net loss of $5.1 million in 2004.
As part of its ongoing evaluation of the recoverability and utilization of its deferred tax assets, in Q4 and for the year, the Company recorded a write off of $1.6 million from its deferred tax assets.
Without the $1.6 million deferred tax assets write off and the $250,000 write off, net loss for the quarter would have been $1.3 million, a reduction from the net loss of $1.6 million in the previous quarter.
Roni Al-Dor, President and CEO, commented "The past three months, my first at Sapiens, have been very exciting for me. We have set out to sharpen focus on the insurance industry while maintaining and supporting our loyal eMerge™ customers. In 2006, we have made some changes to the Company's organizational structure, which include: across the board downsizing, improving our sales force and focusing our marketing efforts in geographical areas of high potential for our solutions.
"As I noted when I joined the Company three months ago, Sapiens has good people, good technology and good software. After these three intensive months, I believe even more that we can turn ourselves around and ride on the road to success."
Mr. Al-Dor, continued: "2006 is a year full of challenges and opportunities for us, such as the first payment of the principal amount of the debentures issued by the Company and promising new opportunities with new insurance customers in old and new markets based on our enhanced and improved suite of products. We believe in our capability to add new customers and penetrate these new markets."
[Tables Follow]
FOR ADDITIONAL INFORMATION:
Elior Brin Chief Financial Officer Sapiens International Tel: +972-8-938-2934 E-mail: IR.Sapiens@sapiens.com | Roni Al-Dor Chief Executive Officer Sapiens International Tel: +972-8-938-2934 E-mail: IR.Sapiens@sapiens.com |
About Sapiens International
Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS), a member of Formula Group (Nasdaq: FORTY) and (TASE: FORT), is a leading global provider of proven IT solutions that modernize business processes and enable insurance organizations to adapt quickly to change. Sapiens' innovative solutions are widely recognized for their ability to cost-effectively align IT with the business demands for speed, flexibility and efficiency. Sapiens operates through its subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific, and has partnerships with market leaders such as IBM and EDS. Sapiens' clients include AXA, Liverpool Victoria, Norwich Union, OneBeacon, Principal Financial Group, Prudential, Abbey National, ING, and Occidental Fire & Casualty among others. For more information, please visit http://www.sapiens.com.
Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of the Company's accounting policies, specific system configurations and software needs of individual customers and other risk factors detailed in the Company's SEC filings.
#
SAPIENS INTERNATIONAL CORPORATION N.V. | |||||||
Condensed Consolidated Balance Sheets | |||||||
(U.S. Dollars in thousands) | |||||||
12/31/2005 | 12/31/2004 | ||||||
Assets | |||||||
Cash and cash equivalents | $ 6,699 | $ 10,942 | |||||
Short-term investments | 5,337 | 11,157 | |||||
Trade receivables, net | 8,339 | 10,028 | |||||
Other current assets | 1,621 | 4,013 | |||||
Total current assets | 21,996 | 36,140 | |||||
Property and equipment, net | 1,716 | 2,382 | |||||
Other assets, net | 28,154 | 30,212 | |||||
Total assets | $ 51,866 | $ 68,734 | |||||
Liabilities and shareholders' equity | |||||||
Short-term bank credit and current maturities | |||||||
of long-term debt and convertible debentures | $ 17,112 | $ 18,873 | |||||
Trade payables | 1,910 | 2,718 | |||||
Other liabilities and accrued expenses | 8,742 | 8,558 | |||||
Deferred revenue | 4,867 | 3,224 | |||||
Total current liabilities | 32,631 | 33,373 | |||||
Long-term debt and other long-term liabilities | 1,584 | 5,035 | |||||
Convertible debentures and warrants | 14,019 | 18,246 | |||||
Shareholders' equity | 3,632 | 12,080 | |||||
Total liabilities and shareholders' equity | $ 51,866 | $ 68,734 | |||||
Note: | Certain prior year's amounts have been reclassified to conform with current year presentation |
#
SAPIENS INTERNATIONAL CORPORATION N.V. | ||||||||
Condensed Consolidated Statements of Income | ||||||||
(U.S. Dollars in thousands, except per share amounts) | ||||||||
For the three months ended | For the year ended | |||||||
12/31/2005 | 12/31/2004 | 12/31/2005 | 12/31/2004 | |||||
Revenues | ||||||||
Products | $ 4,833 | $ 6,716 | $ 19,802 | $ 26,781 | ||||
Consulting and other services | 4,938 | 5,313 | 19,602 | 21,023 | ||||
Total revenues | 9,771 | 12,029 | 39,404 | 47,804 | ||||
Cost of revenues | ||||||||
Products | 3,696 | 3,845 | 14,619 | 16,578 | ||||
Consulting and other services | 2,571 | 2,903 | 10,227 | 10,186 | ||||
Impairment of capitalized software development costs | - | 901 | - | 901 | ||||
Total cost of revenues | 6,267 | 7,649 | 24,846 | 27,665 | ||||
Gross Profit | 3,504 | 4,380 | 14,558 | 20,139 | ||||
Operating expenses | ||||||||
Research and development, net | 480 | 582 | 2,723 | 2,531 | ||||
Selling, marketing, general and administrative | 3,987 | 4,626 | 16,245 | 19,260 | ||||
Restructuring expenses | - | - | 1,113 | - | ||||
Operating Loss | 963 | 828 | 5,523 | 1,652 | ||||
Financial expenses, net | 407 | 725 | 1,788 | 2,410 | ||||
Other expenses, net * | 1,747 | 147 | 1,788 | 780 | ||||
Net Loss | 3,117 | 1,700 | 9,099 | 4,842 | ||||
Settlement of redeemable shares in a subsidiary | - | - | - | 299 | ||||
Net Loss to shareholders of common shares | $ 3,117 | $ 1,700 | $ 9,099 | $ 5,141 | ||||
Basic and diluted loss per share | $ 0.25 |
| $ 0.15 |
| $ 0.76 |
| $ 0.46 | |
Weighted average shares used to compute - basic and diluted loss per share | 12,492 | 11,449 | 11,982 | 11,273 | ||||
Note | * Includes taxes and minority interest |
#
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Sapiens International Corporation N.V.
(Registrant)
Date: February 23, 2006
By:
/s/ Andrew Treitel
Andrew Treitel
General Counsel and Corporate Secretary